Your browser doesn't support javascript.
loading
Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
Scirica, Benjamin M; Im, KyungAh; Murphy, Sabina A; Kuder, Julia F; Rodriguez, Dolly A; Lopes, Renato D; Green, Jennifer B; Ruff, Christian T; Sabatine, Marc S.
Afiliação
  • Scirica BM; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Im K; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Murphy SA; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kuder JF; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Rodriguez DA; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Lopes RD; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Green JB; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Ruff CT; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Sabatine MS; TIMI Study Group, Cardiovascular Medicine Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Clin Cardiol ; 45(7): 794-801, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35715946

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article